Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Homovanillic acid (HVA) is a dopamine metabolite, a monocarboxylic acid that is the 3-O-methyl ether of (3,4-dihydroxyphenyl)acetic acid. It is a white to beige crystalline powder, formed via deamination of dopamine by monoamine oxidase (MAO) to produce 3,4-dihydroxyphenylacetic acid (DOPAC), followed by DOPAC metabolism by catechol-O-methyltransferase (COMT). HVA undergoes hydrogen peroxide-dependent oxidation in the presence of horseradish peroxidase to form a fluorescent dimer that displays excitation/emission maxima of 312/420 nm, respectively.

306-08-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 306-08-1 Structure
  • Basic information

    1. Product Name: Homovanillic acid
    2. Synonyms: 4-Hydroxy-3-methoxybenzeneacetic acid;4-hydroxy-3-methoxy-benzeneaceticaci;4-hydroxy-3-methoxy-Benzeneaceticacid;Acetic acid, (4-hydroxy-3-methoxyphenyl)-;Homovanilic acid;Homovanillinic acid;Vanilacetic acid;Vanillacetic Acid
    3. CAS NO:306-08-1
    4. Molecular Formula: C9H10O4
    5. Molecular Weight: 182.17
    6. EINECS: 206-176-7
    7. Product Categories: Pharmaceutical Intermediates;Multisubstituted Benzene;Aromatics;Intermediates & Fine Chemicals;Metabolites & Impurities;Pharmaceuticals;chemical reagent;pharmaceutical intermediate;phytochemical;reference standards from Chinese medicinal herbs (TCM).;standardized herbal extract
    8. Mol File: 306-08-1.mol
  • Chemical Properties

    1. Melting Point: 142-145 °C(lit.)
    2. Boiling Point: 235.56°C (rough estimate)
    3. Flash Point: 151.9 °C
    4. Appearance: White to beige/Crystalline Powder
    5. Density: 1.1634 (rough estimate)
    6. Vapor Pressure: 4.36E-06mmHg at 25°C
    7. Refractive Index: 1.4209 (estimate)
    8. Storage Temp.: Store at RT.
    9. Solubility: DMSO (Slightly), Methanol (Slightly, Heated)
    10. PKA: 4.39±0.10(Predicted)
    11. Water Solubility: soluble
    12. Stability: Hygroscopic
    13. Merck: 14,4740
    14. BRN: 2213447
    15. CAS DataBase Reference: Homovanillic acid(CAS DataBase Reference)
    16. NIST Chemistry Reference: Homovanillic acid(306-08-1)
    17. EPA Substance Registry System: Homovanillic acid(306-08-1)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 36/37/38
    3. Safety Statements: 26-36
    4. WGK Germany: 3
    5. RTECS:
    6. F: 10-23
    7. TSCA: T
    8. HazardClass: IRRITANT
    9. PackingGroup: N/A
    10. Hazardous Substances Data: 306-08-1(Hazardous Substances Data)

306-08-1 Usage

Uses

Used in Medical Applications:
Homovanillic acid is used as a neuroendocrine tumor marker for the diagnosis of neuroblastoma and malignant pheochromocytoma. Its presence in the body is associated with dopamine levels in the brain, supporting the diagnosis of these conditions.
Used in Research and Diagnostics:
HVA is used as a fluorimetric reagent and a major catecholamine metabolite in the determination of oxidative enzymes. It has been utilized to quantify hydrogen peroxide production in macrophages and neutrophils, contributing to the understanding of various biological processes and disease mechanisms.
Used in Pharmaceutical Industry:
Homovanillic acid is used as a reagent in the pharmaceutical industry for the development and testing of drugs targeting the dopaminergic system, as it is directly related to dopamine metabolism and neurotransmission.

Biological Activity

Fluorimetric reagent and major catecholamine metabolite. Used for fluorimetric determination of oxidative enzymes including glucose oxidase.

Check Digit Verification of cas no

The CAS Registry Mumber 306-08-1 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 3,0 and 6 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 306-08:
(5*3)+(4*0)+(3*6)+(2*0)+(1*8)=41
41 % 10 = 1
So 306-08-1 is a valid CAS Registry Number.
InChI:InChI=1/C9H10O4/c1-13-8-4-6(5-9(11)12)2-3-7(8)10/h2-4,10H,5H2,1H3,(H,11,12)/p-1

306-08-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A12441)  Homovanillic acid, 98+%   

  • 306-08-1

  • 1g

  • 595.0CNY

  • Detail
  • Alfa Aesar

  • (A12441)  Homovanillic acid, 98+%   

  • 306-08-1

  • 5g

  • 2025.0CNY

  • Detail
  • Alfa Aesar

  • (A12441)  Homovanillic acid, 98+%   

  • 306-08-1

  • 25g

  • 7043.0CNY

  • Detail

306-08-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name homovanillic acid

1.2 Other means of identification

Product number -
Other names Homovanillinic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:306-08-1 SDS

306-08-1Synthetic route

4-hydroxy-3-methoxyphenylacetonitrile
4468-59-1

4-hydroxy-3-methoxyphenylacetonitrile

Homovanillic acid
306-08-1

Homovanillic acid

Conditions
ConditionsYield
With sodium hydroxide In ethanol; water at 80℃; for 48h; Inert atmosphere;89%
With potassium hydroxide In ethanol Heating;74%
With sodium hydroxide In 2-methoxy-ethanol
4-hydroxy-3-methoxy-mandelic acid
55-10-7

4-hydroxy-3-methoxy-mandelic acid

Homovanillic acid
306-08-1

Homovanillic acid

Conditions
ConditionsYield
With hydrogenchloride; tin(ll) chloride In water at 80℃; for 4h;88%
75%
With 5%-palladium/activated carbon; hydrogen; acetic acid In water
3-methoxy-4-hydroxy mandelic acid
13244-77-4

3-methoxy-4-hydroxy mandelic acid

Homovanillic acid
306-08-1

Homovanillic acid

Conditions
ConditionsYield
With formic acid; phosphoric acid; sodium hydrogensulfite In water at 100℃; under 3750.3 Torr; for 9h;71%
4-Acetoxy-3-methoxyphenylacetaldehyde
6391-59-9

4-Acetoxy-3-methoxyphenylacetaldehyde

A

Homovanillic acid
306-08-1

Homovanillic acid

B

2-(4-acetoxy-3-methoxyphenyl)acetic acid
5447-38-1

2-(4-acetoxy-3-methoxyphenyl)acetic acid

Conditions
ConditionsYield
With potassium permanganate; magnesium sulfate; acetone
4-(4-acetoxy-3-methoxy-benzylidene)-2-methyl-4H-oxazol-5-one
60470-82-8, 39600-31-2

4-(4-acetoxy-3-methoxy-benzylidene)-2-methyl-4H-oxazol-5-one

Homovanillic acid
306-08-1

Homovanillic acid

Conditions
ConditionsYield
With sodium hydroxide anschliessend Behandeln mit wss. H2O2;
2-(4-acetoxy-3-methoxyphenyl)acetic acid
5447-38-1

2-(4-acetoxy-3-methoxyphenyl)acetic acid

Homovanillic acid
306-08-1

Homovanillic acid

Conditions
ConditionsYield
With sodium hydroxide
m-methoxy-p-acetoxy-α-benzoylaminocinnamic acid azlactone
18692-68-7, 71413-82-6, 74857-79-7

m-methoxy-p-acetoxy-α-benzoylaminocinnamic acid azlactone

furan-2,3,5(4H)-trione pyridine (1:1)

furan-2,3,5(4H)-trione pyridine (1:1)

Homovanillic acid
306-08-1

Homovanillic acid

Conditions
ConditionsYield
folgend Behandeln mit Wasserstoffperoxyd in Eisessig;
(4-acetoxy-3-methoxy-phenyl)-acetonitrile
5438-51-7

(4-acetoxy-3-methoxy-phenyl)-acetonitrile

Homovanillic acid
306-08-1

Homovanillic acid

Conditions
ConditionsYield
With potassium hydroxide
1-benzoyloxy-4-chloromethyl-2-methoxy-benzene
873376-14-8

1-benzoyloxy-4-chloromethyl-2-methoxy-benzene

Homovanillic acid
306-08-1

Homovanillic acid

Conditions
ConditionsYield
With potassium cyanide anschliessend Erhitzen mit wss. Natronlauge;

A

Homovanillic acid
306-08-1

Homovanillic acid

B

5-[2-(4-Hydroxy-3-methoxy-phenyl)-ethyl]-dihydro-furan-2-one

5-[2-(4-Hydroxy-3-methoxy-phenyl)-ethyl]-dihydro-furan-2-one

Conditions
ConditionsYield
for 168h; biotransformation by aspergillus niger;A 60 mg
B 36 mg
4-benzyloxy-3-methoxyphenylacetic acid
29973-91-9

4-benzyloxy-3-methoxyphenylacetic acid

Homovanillic acid
306-08-1

Homovanillic acid

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal In ethanol
trans-coniferyl aldehyde
458-36-6

trans-coniferyl aldehyde

A

methoxyhydroquinone
824-46-4

methoxyhydroquinone

B

3-methoxy-4-hydroxybenzoic acid
121-34-6

3-methoxy-4-hydroxybenzoic acid

C

Homovanillic acid
306-08-1

Homovanillic acid

D

vanillin
121-33-5

vanillin

Conditions
ConditionsYield
With peracetic acid In ethanol for 1h; pH=7; Product distribution; Further Variations:; Reagents; Oxidation;A 10.1 % Chromat.
B 13.6 % Chromat.
C 10.9 % Chromat.
D 7.1 % Chromat.
4-Acetoxy-3-methoxyphenylacetaldehyde
6391-59-9

4-Acetoxy-3-methoxyphenylacetaldehyde

magnesium sulfate
7487-88-9

magnesium sulfate

acetone
67-64-1

acetone

KMnO4

KMnO4

A

Homovanillic acid
306-08-1

Homovanillic acid

B

2-(4-acetoxy-3-methoxyphenyl)acetic acid
5447-38-1

2-(4-acetoxy-3-methoxyphenyl)acetic acid

azlactone of/the/ 3-methoxy-4-acetoxy-α-benzamino-cinnamic acid

azlactone of/the/ 3-methoxy-4-acetoxy-α-benzamino-cinnamic acid

Homovanillic acid
306-08-1

Homovanillic acid

Conditions
ConditionsYield
With sodium hydroxide man gibt zu der Loesung erst Eisessig und dann H2O2;
(3-methoxy-4-oxo-cyclohexa-2,5-dienyliden)-acetonitrile
91054-36-3

(3-methoxy-4-oxo-cyclohexa-2,5-dienyliden)-acetonitrile

hydrogen iodide
10034-85-2

hydrogen iodide

A

Homovanillic acid
306-08-1

Homovanillic acid

B

2,3-bis-(4-hydroxy-3-methoxy-phenyl)-succinonitrile

2,3-bis-(4-hydroxy-3-methoxy-phenyl)-succinonitrile

Conditions
ConditionsYield
5-min. Erhitzen;
4-amino-butyric acid 2-(4-hydroxy-3-methoxy-phenyl)-2-oxo-ethyl ester
284043-11-4

4-amino-butyric acid 2-(4-hydroxy-3-methoxy-phenyl)-2-oxo-ethyl ester

A

Homovanillic acid
306-08-1

Homovanillic acid

B

2,4'-dihydroxy-3'-methoxyacetophenone
18256-48-9

2,4'-dihydroxy-3'-methoxyacetophenone

C

1-(3-methoxy-4-hydroxyphenyl)ethanone
498-02-2

1-(3-methoxy-4-hydroxyphenyl)ethanone

D

4-amino-n-butyric acid
56-12-2

4-amino-n-butyric acid

Conditions
ConditionsYield
With water Hydrolysis; reduction; rearrangement; UV-irradiation;
γ-O-(4-hydroxy-3-methoxyphenacetyl) L-glutamate, trifuoroacetate salt

γ-O-(4-hydroxy-3-methoxyphenacetyl) L-glutamate, trifuoroacetate salt

A

L-glutamic acid
56-86-0

L-glutamic acid

B

Homovanillic acid
306-08-1

Homovanillic acid

C

2,4'-dihydroxy-3'-methoxyacetophenone
18256-48-9

2,4'-dihydroxy-3'-methoxyacetophenone

D

1-(3-methoxy-4-hydroxyphenyl)ethanone
498-02-2

1-(3-methoxy-4-hydroxyphenyl)ethanone

Conditions
ConditionsYield
With water Hydrolysis; rearrangement; reduction; UV-irradiation;
4-hydroxymethyl-2-methoxyphenol
498-00-0

4-hydroxymethyl-2-methoxyphenol

Homovanillic acid
306-08-1

Homovanillic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 60 percent / dimethylformamide / 20 h / 130 °C
2: 74 percent / KOH / ethanol / Heating
View Scheme
Multi-step reaction with 2 steps
1: N,N-dimethyl-formamide / 24 h / 120 °C / Inert atmosphere
2: sodium hydroxide / ethanol; water / 48 h / 80 °C / Inert atmosphere
View Scheme
α-bromo-3-methoxy-4-hydroxyacetophenone
69638-06-8

α-bromo-3-methoxy-4-hydroxyacetophenone

Homovanillic acid
306-08-1

Homovanillic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: DBU / dioxane / 12 h / 0 - 20 °C
2: TFA / 4 h / 0 °C
3: H2O / UV-irradiation
View Scheme
Multi-step reaction with 3 steps
1: 57 percent / DBU / benzene / 12 h / 20 °C
2: 95.3 percent / TFA / 4 h / 0 °C
3: H2O / UV-irradiation
View Scheme
1-(3-methoxy-4-hydroxyphenyl)ethanone
498-02-2

1-(3-methoxy-4-hydroxyphenyl)ethanone

Homovanillic acid
306-08-1

Homovanillic acid

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 47 percent / cupric bromide / CHCl3; ethyl acetate / 4 h / 20 °C
2: DBU / dioxane / 12 h / 0 - 20 °C
3: TFA / 4 h / 0 °C
4: H2O / UV-irradiation
View Scheme
Multi-step reaction with 4 steps
1: 47 percent / cupric bromide / CHCl3; ethyl acetate / 4 h / 20 °C
2: 57 percent / DBU / benzene / 12 h / 20 °C
3: 95.3 percent / TFA / 4 h / 0 °C
4: H2O / UV-irradiation
View Scheme
2-(4-hydroxy-3-methoxyphenyl)-2-oxoethyl-4-[(tert-butoxycarbonyl)amino]butanoate
284043-13-6

2-(4-hydroxy-3-methoxyphenyl)-2-oxoethyl-4-[(tert-butoxycarbonyl)amino]butanoate

Homovanillic acid
306-08-1

Homovanillic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: TFA / 4 h / 0 °C
2: H2O / UV-irradiation
View Scheme
γ-O-(4-hydroxy-3-methoxyphenacetyl) t-butyl N-t-boc L-glutamate
284043-05-6

γ-O-(4-hydroxy-3-methoxyphenacetyl) t-butyl N-t-boc L-glutamate

Homovanillic acid
306-08-1

Homovanillic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 95.3 percent / TFA / 4 h / 0 °C
2: H2O / UV-irradiation
View Scheme
methyl 4-benzyloxy-3-methoxyphenylethanoate
16209-54-4

methyl 4-benzyloxy-3-methoxyphenylethanoate

Homovanillic acid
306-08-1

Homovanillic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 10percent KOH / methanol; H2O
2: H2 / 10percent Pd-C / aq. ethanol
View Scheme
4-(hydroxymethyl)-2-methoxyphenyl benzoate
174840-51-8

4-(hydroxymethyl)-2-methoxyphenyl benzoate

Homovanillic acid
306-08-1

Homovanillic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: calcium chloride; thionyl chloride
2: aqueous potassium cyanide / anschliessend Erhitzen mit wss. Natronlauge
View Scheme
eugenol acetate
93-28-7

eugenol acetate

Homovanillic acid
306-08-1

Homovanillic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: ethyl acetate; ozone / und anschliesende Hydrierung an Palladium/Kohle
2: potassium permanganate; magnesium sulfate; aqueous acetone
View Scheme
Multi-step reaction with 2 steps
1: KMnO4; water
2: NaOH-solution
View Scheme
4-allylguaiacol
97-53-0

4-allylguaiacol

Homovanillic acid
306-08-1

Homovanillic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
2: KMnO4; water
3: NaOH-solution
View Scheme
2-methoxy-4-((methylamino)methyl)phenol
42973-53-5

2-methoxy-4-((methylamino)methyl)phenol

Homovanillic acid
306-08-1

Homovanillic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: dimethylformamide
2: aq. NaOH / 2-methoxy-ethanol
View Scheme
vanillin
121-33-5

vanillin

Homovanillic acid
306-08-1

Homovanillic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: (i) EtOH, (ii) H2, PtO2
2: dimethylformamide
3: aq. NaOH / 2-methoxy-ethanol
View Scheme
Multi-step reaction with 3 steps
1: sodium tetrahydroborate / methanol / 24.5 h / 0 - 20 °C / Inert atmosphere
2: N,N-dimethyl-formamide / 24 h / 120 °C / Inert atmosphere
3: sodium hydroxide / ethanol; water / 48 h / 80 °C / Inert atmosphere
View Scheme
8-O-4′-diferulic acid
215872-63-2

8-O-4′-diferulic acid

A

3-(4-hydroxy-3-methoxyphenyl)acrylic acid
1135-24-6

3-(4-hydroxy-3-methoxyphenyl)acrylic acid

B

3-(3-hydroxyphenyl)-propanoic acid
621-54-5

3-(3-hydroxyphenyl)-propanoic acid

C

3-(4-hydroxy-3-methoxyphenyl)propionic acid
1135-23-5

3-(4-hydroxy-3-methoxyphenyl)propionic acid

D

caffeic acid
331-39-5

caffeic acid

E

3,4-dihydroxyphenylacetate
102-32-9

3,4-dihydroxyphenylacetate

F

Homovanillic acid
306-08-1

Homovanillic acid

G

dihydrocaffeic acid
1078-61-1

dihydrocaffeic acid

H

danshensu
23028-17-3

danshensu

I

3-(4-hydroxy-3-methoxyphenyl)lactic acid
2475-56-1

3-(4-hydroxy-3-methoxyphenyl)lactic acid

J

3-(4-hydroxy-3-methoxyphenyl)-2-oxopropanoic acid
1081-71-6

3-(4-hydroxy-3-methoxyphenyl)-2-oxopropanoic acid

Conditions
ConditionsYield
With D-glucose In dimethyl sulfoxide at 37℃; aq. buffer; anaerobic atmosphere; Enzymatic reaction;
methanol
67-56-1

methanol

Homovanillic acid
306-08-1

Homovanillic acid

2-(4-hydroxy-3-methoxyphenyl)acetic acid methyl ester
15964-80-4

2-(4-hydroxy-3-methoxyphenyl)acetic acid methyl ester

Conditions
ConditionsYield
With sulfuric acid for 3h; Reflux;100%
With toluene-4-sulfonic acid
With sulfuric acid at 20℃; for 4h; Reflux;
Homovanillic acid
306-08-1

Homovanillic acid

isopropyl bromide
75-26-3

isopropyl bromide

isopropyl 2-(4-isopropoxy-3-methoxyphenyl)acetate
1256581-67-5

isopropyl 2-(4-isopropoxy-3-methoxyphenyl)acetate

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide for 24h; Reflux; Inert atmosphere;100%
Homovanillic acid
306-08-1

Homovanillic acid

recorcinol
108-46-3

recorcinol

1-(2,4-dihydroxyphenyl)-2-(4'-hydroxy-3'-methoxyphenyl)ethanone
40456-49-3

1-(2,4-dihydroxyphenyl)-2-(4'-hydroxy-3'-methoxyphenyl)ethanone

Conditions
ConditionsYield
With boron trifluoride diethyl etherate at 60 - 70℃; for 1h;99%
With bis(trifluoromethanesulfonyl)amide In various solvent(s) at 90℃; for 0.0666667h; Friedel-Crafts reaction; microwave irradiation;70%
With boron trifluoride diethyl etherate In N,N-dimethyl-formamide at 120℃; for 0.166667h; Friedel-Crafts reaction;57%
ethanol
64-17-5

ethanol

Homovanillic acid
306-08-1

Homovanillic acid

ethyl homovanillate
60563-13-5

ethyl homovanillate

Conditions
ConditionsYield
With sulfuric acid for 2h; Reflux;99%
With sulfuric acid99%
With sulfuric acid for 2h; Reflux;80%
With sulfuric acid Reflux;
With sulfuric acid at 90℃; for 7h;
Homovanillic acid
306-08-1

Homovanillic acid

tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

tert-butyldimethyl 2-(4-(tert-butyldimethylsilyloxy)-3-methoxyphenyl)acetate
78324-15-9

tert-butyldimethyl 2-(4-(tert-butyldimethylsilyloxy)-3-methoxyphenyl)acetate

Conditions
ConditionsYield
With 1H-imidazole In tetrahydrofuran at 20℃; for 14h; Inert atmosphere;98%
With 1H-imidazole In tetrahydrofuran at 20℃; for 14h; Inert atmosphere;64%
With 1H-imidazole In N,N-dimethyl-formamide at 0 - 20℃; for 3h;
Homovanillic acid
306-08-1

Homovanillic acid

2-(3,4-dihydroxy-5-methoxyphenyl)acetic acid
2989-10-8

2-(3,4-dihydroxy-5-methoxyphenyl)acetic acid

Conditions
ConditionsYield
With Agaricus bisporus; oxygen In aq. phosphate buffer; dichloromethane at 25℃; for 24h; pH=7;98%
Homovanillic acid
306-08-1

Homovanillic acid

acetic anhydride
108-24-7

acetic anhydride

2-(4-acetoxy-3-methoxyphenyl)acetic acid
5447-38-1

2-(4-acetoxy-3-methoxyphenyl)acetic acid

Conditions
ConditionsYield
With sulfuric acid97%
With sulfuric acid Ambient temperature;79%
2-(methylamino)-1-phenylethanol
68579-60-2

2-(methylamino)-1-phenylethanol

Homovanillic acid
306-08-1

Homovanillic acid

2-(4-hydroxy-3-methoxy-phenyl)-N-(2-hydroxy-2-phenyl-ethyl)-N-methyl-acetamide
749247-36-7

2-(4-hydroxy-3-methoxy-phenyl)-N-(2-hydroxy-2-phenyl-ethyl)-N-methyl-acetamide

Conditions
ConditionsYield
With benzotriazol-1-ol; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide In dichloromethane97%
4-Methylbenzyl alcohol
589-18-4

4-Methylbenzyl alcohol

Homovanillic acid
306-08-1

Homovanillic acid

1-(4-hydroxy-3-methoxyphenyl)-3-(4-methylphenyl)propan-2-one

1-(4-hydroxy-3-methoxyphenyl)-3-(4-methylphenyl)propan-2-one

Conditions
ConditionsYield
Stage #1: 4-Methylbenzyl alcohol; Homovanillic acid With dmap; dicyclohexyl-carbodiimide In 1,2-dichloro-ethane at 55℃; for 4h;
Stage #2: With sodium tetrahydroborate In tetrahydrofuran for 2h; Temperature; Inert atmosphere; Cooling with ice;
96.8%
Homovanillic acid
306-08-1

Homovanillic acid

benzyl bromide
100-39-0

benzyl bromide

benzyl 2-(4-(benzyloxy)-3-methoxyphenyl)acetate
65340-85-4

benzyl 2-(4-(benzyloxy)-3-methoxyphenyl)acetate

Conditions
ConditionsYield
With potassium carbonate In acetonitrile for 4h; Reflux;95%
With potassium carbonate In acetonitrile at 80℃; for 8h;88%
With sodium In methanol
trifluoromethylsulfonic anhydride
358-23-6

trifluoromethylsulfonic anhydride

Homovanillic acid
306-08-1

Homovanillic acid

2-(3-methoxy-4-(trifluoromethylsulfonyloxy)phenyl)acetic acid
1243245-99-9

2-(3-methoxy-4-(trifluoromethylsulfonyloxy)phenyl)acetic acid

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0℃;95%
Homovanillic acid
306-08-1

Homovanillic acid

4-Methoxyphenethylamine
55-81-2

4-Methoxyphenethylamine

2-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-methoxyphenyl)ethyl]acetamide
1395084-66-8

2-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-methoxyphenyl)ethyl]acetamide

Conditions
ConditionsYield
In 5,5-dimethyl-1,3-cyclohexadiene for 16h; Reflux; Inert atmosphere;95%
Homovanillic acid
306-08-1

Homovanillic acid

N-(benzyloxy)octan-1-amine
122149-21-7

N-(benzyloxy)octan-1-amine

N-benzyloxy-N-octyl-2-(4-hydroxy-3-methoxyphenyl)acetamide
1400943-51-2

N-benzyloxy-N-octyl-2-(4-hydroxy-3-methoxyphenyl)acetamide

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane for 4.5h; Inert atmosphere;94%
Homovanillic acid
306-08-1

Homovanillic acid

O-benzyl-N-heptylhydroxylamine
112151-61-8

O-benzyl-N-heptylhydroxylamine

N-benzyloxy-N-heptyl-2-(4-hydroxy-3-methoxyphenyl)acetamide
1400943-49-8

N-benzyloxy-N-heptyl-2-(4-hydroxy-3-methoxyphenyl)acetamide

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane93%
Homovanillic acid
306-08-1

Homovanillic acid

Phenyl-acetic acid (1aR,1bS,4aS,7aS,7bS,8R,9R,9aS)-9a-acetoxy-4a,7b-dihydroxy-3-hydroxymethyl-1,1,6,8-tetramethyl-5-oxo-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-1H-cyclopropa[3,4]benzo[1,2-e]azulen-9-yl ester
850163-67-6

Phenyl-acetic acid (1aR,1bS,4aS,7aS,7bS,8R,9R,9aS)-9a-acetoxy-4a,7b-dihydroxy-3-hydroxymethyl-1,1,6,8-tetramethyl-5-oxo-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-1H-cyclopropa[3,4]benzo[1,2-e]azulen-9-yl ester

13-acetyl-20-homovanillyl-12-phenylacetyl-4α-phorbol
777859-96-8

13-acetyl-20-homovanillyl-12-phenylacetyl-4α-phorbol

Conditions
ConditionsYield
With di-tert-butyl-diazodicarboxylate; triphenylphosphine In tetrahydrofuran at 20℃; for 1h;91%
Å molecular sieve

Å molecular sieve

Homovanillic acid
306-08-1

Homovanillic acid

3-(3,4-dimethylphenyl)propylamine
142332-70-5

3-(3,4-dimethylphenyl)propylamine

KR-25003
142333-36-6

KR-25003

Conditions
ConditionsYield
In dichloromethane90%
Homovanillic acid
306-08-1

Homovanillic acid

3-(3,4-dimethylphenyl)propylamine
142332-70-5

3-(3,4-dimethylphenyl)propylamine

KR-25003
142333-36-6

KR-25003

Conditions
ConditionsYield
molecular sieve In dichloromethane90%
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; for 15h;
Homovanillic acid
306-08-1

Homovanillic acid

benzylamine
100-46-9

benzylamine

N-benzyl-4-hydroxy-3-methoxyphenylacetamide
391609-30-6

N-benzyl-4-hydroxy-3-methoxyphenylacetamide

Conditions
ConditionsYield
With 4 A molecular sieve at 140 - 150℃; for 3h;89%
Homovanillic acid
306-08-1

Homovanillic acid

3-iodobenzylamine hydrochloride
3718-88-5

3-iodobenzylamine hydrochloride

2-(4-hydroxy-3-methoxyphenyl)-N-(3-iodobenzyl)acetamide
873099-30-0

2-(4-hydroxy-3-methoxyphenyl)-N-(3-iodobenzyl)acetamide

Conditions
ConditionsYield
With 1-hydroxy-7-aza-benzotriazole; triethylamine; dicyclohexyl-carbodiimide In tetrahydrofuran at 20℃;88%
Homovanillic acid
306-08-1

Homovanillic acid

2-(3-methoxyphenyl)-1-ethanamine
2039-67-0

2-(3-methoxyphenyl)-1-ethanamine

2-(4-hydroxy-3-methoxyphenyl)-N-[2-(3-methoxyphenyl)ethyl]acetamide

2-(4-hydroxy-3-methoxyphenyl)-N-[2-(3-methoxyphenyl)ethyl]acetamide

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In N,N-dimethyl-formamide at 70℃; for 4h;88%
methanol
67-56-1

methanol

Homovanillic acid
306-08-1

Homovanillic acid

trimethyl orthoformate
149-73-5

trimethyl orthoformate

2-(4-hydroxy-3-methoxyphenyl)acetic acid methyl ester
15964-80-4

2-(4-hydroxy-3-methoxyphenyl)acetic acid methyl ester

Conditions
ConditionsYield
With sulfuric acid for 18h; Heating / reflux;85%
3,3-dimethyl-5-[4-(trifluoromethyl)phenyl]-2,3-dihydro-1H-indole
844901-56-0

3,3-dimethyl-5-[4-(trifluoromethyl)phenyl]-2,3-dihydro-1H-indole

Homovanillic acid
306-08-1

Homovanillic acid

4-(2-{3,3-dimethyl-5-[4-(trifluoromethyl)phenyl]-2,3-dihydro-1H-indol-1-yl}-2-oxoethyl)-2-methoxyphenol
847064-35-1

4-(2-{3,3-dimethyl-5-[4-(trifluoromethyl)phenyl]-2,3-dihydro-1H-indol-1-yl}-2-oxoethyl)-2-methoxyphenol

Conditions
ConditionsYield
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In 1,2-dichloro-ethane at 0 - 20℃;82%
8-methyl-1-nonanol
55505-26-5

8-methyl-1-nonanol

Homovanillic acid
306-08-1

Homovanillic acid

8-methylnonyl homovanillate
951221-76-4

8-methylnonyl homovanillate

Conditions
ConditionsYield
With magnesium sulfate; novozyme 435 In toluene at 50℃; for 16h; Enzymatic reaction;81.5%
Homovanillic acid
306-08-1

Homovanillic acid

2-(3,4-dimethoxyphenyl)-ethylamine
120-20-7

2-(3,4-dimethoxyphenyl)-ethylamine

N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(3-hydroxy-4-methoxyphenyl)acetamide
361389-65-3

N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(3-hydroxy-4-methoxyphenyl)acetamide

Conditions
ConditionsYield
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; Inert atmosphere;79%
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; Inert atmosphere;79%
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 20℃;
propan-1-ol
71-23-8

propan-1-ol

Homovanillic acid
306-08-1

Homovanillic acid

Propyl-2-(4-hydroxy-3-methoxy-phenyl)acetate
52744-26-0

Propyl-2-(4-hydroxy-3-methoxy-phenyl)acetate

Conditions
ConditionsYield
With acetyl chloride at 60℃; for 3h;78.2%
With sulfuric acid at 90℃; for 7h;
2-phenylethanol
60-12-8

2-phenylethanol

Homovanillic acid
306-08-1

Homovanillic acid

2-phenylethyl 2-(4-hydroxy-3-methoxyphenyl)acetate

2-phenylethyl 2-(4-hydroxy-3-methoxyphenyl)acetate

Conditions
ConditionsYield
With di-isopropyl azodicarboxylate; thiamine diphosphate In tetrahydrofuran at 20℃; Mitsunobu esterification;78%
2-Phenoxyethanol
122-99-6

2-Phenoxyethanol

Homovanillic acid
306-08-1

Homovanillic acid

2-phenoxyethyl 2-(4-hydroxy-3-methoxyphenyl)acetate

2-phenoxyethyl 2-(4-hydroxy-3-methoxyphenyl)acetate

Conditions
ConditionsYield
With sulfuric acid In toluene for 2h; Dean-Stark; Reflux;77.3%
piperidine
110-89-4

piperidine

Homovanillic acid
306-08-1

Homovanillic acid

2-(4-Hydroxy-3-methoxy-phenyl)-1-piperidin-1-yl-ethanone
53283-49-1

2-(4-Hydroxy-3-methoxy-phenyl)-1-piperidin-1-yl-ethanone

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; for 3h;75%

306-08-1Relevant articles and documents

Design, synthesis, and evaluation of phenylpiperazine-phenylacetate derivatives as rapid recovery hypnotic agents

Qi, Zhaoyang,Li, Ziying,Zhu, Mo,Zhang, Xiaohua,Zhang, Guisen,Zhuang, Tao,Chen, Yin,Huang, Ling

, (2021/12/20)

In this paper, we designed and synthesized a series of novel phenylpiperazine-phenylacetate derivatives as rapid recovery hypnotic agents. The best compound 10 had relatively high affinity for the GABAA receptor and low affinity for thirteen other off-target receptors. In three animal models (mice, rats, and rabbits), compound 10 exerted potent hypnotic effects (HD50 = 5.2 mg/kg in rabbits), comparable duration of the loss of righting reflex (LORR), and significant shorter recovery time (time to walk) than propanidid. Furthermore, compound 10 (TI = 18.1) showed higher safety profile than propanidid (TI = 14.7) in rabbits. Above results suggested that compound 10 may have predictable and rapid recovery profile in anesthesia.

Specific Residues Expand the Substrate Scope and Enhance the Regioselectivity of a Plant O-Methyltransferase

Tang, Qingyun,Bornscheuer, Uwe T.,Pavlidis, Ioannis V.

, p. 3227 - 3233 (2019/07/04)

An isoeugenol 4-O-methyltransferase (IeOMT), isolated from the plant Clarkia breweri, can be engineered to a caffeic acid 3-O-methyltransferase (CaOMT) by replacing three consecutive residues. Here we further investigated functions of these residues by constructing the triple mutant T133M/A134N/T135Q as well as single mutants of each residue. Phenolics with different chain lengths and different functional groups were investigated. The variant T133M improves the enzymatic activities against all tested substrates by providing beneficial interactions to residues which directly interact with the substrate. Mutant A134N significantly enhanced the regioselectivity. It is meta-selective or even specific against most of the tested substrates but para-specific towards 3,4-dihydroxybenzoic acid. The triple mutant T133M/A134N/T135Q benefits from these two mutations, which not only expand the substrate scope but also enhance the regioselectivity of IeOMT. On the basis of our work, regiospecific methylated phenolics can be produced in high purity by different IeOMT variants.

Phenylacetic acid ester compound and use thereof

-

Paragraph 0059; 0065; 0066, (2019/03/02)

The invention relates to a phenylacetate compound as shown in a general formula (I) and a pharmaceutical composition containing the phenylacetate compound, as well as application in anesthesia and sedation.

Biological evaluation of natural and synthesized homovanillic acid esters as inhibitors of intestinal fatty acid uptake in differentiated Caco-2 cells

Lieder, Barbara,Hans, Joachim,Hentschel, Fabia,Geissler, Katrin,Ley, Jakob

, (2019/10/14)

With raising prevalence of obesity, the regulation of human body fat is increasingly relevant. The modulation of fatty acid uptake by enterocytes represents a promising target for body weight maintenance. Recent results demonstrated that the trigeminal active compounds capsaicin, nonivamide, and trans-pellitorine dose-dependently reduce fatty acid uptake in differentiated Caco-2 cells as a model for the intestinal barrier. However, non-pungent alternatives have not been investigated and structural determinants for the modulation of intestinal fatty acid uptake have not been identified so far. Thus, based on the previous results, we synthesized 23 homovanillic acid esters in addition to the naturally occurring capsiate and screened them for their potential to reduce intestinal fatty acid uptake using the fluorescent fatty acid analog Bodipy-C12 in differentiated Caco-2 cells as an enterocyte model. Whereas pre-incubation with 100 μM capsiate did not change fatty acid uptake by Caco-2 enterocytes, a maximum inhibition of ?47% was reached using 100 μM 1-methylpentyl-2-(4-hydroxy-3-methoxy-phenyl)acetate. Structural analysis of the 24 structural analogues tested in the present study revealed that a branched fatty acid side chain, independent of the chain length, is one of the most important structural motifs associated with inhibition of fatty acid uptake in Caco-2 enterocytes. The results of the present study may serve as an important basis for designing potent dietary inhibitors of fatty acid uptake.

Electrochemical Lignin Degradation in Ionic Liquids on Ternary Mixed Metal Electrodes

Rauber, Daniel,Dier, Tobias K.F.,Volmer, Dietrich A.,Hempelmann, Rolf

, p. 189 - 208 (2017/12/18)

Lignin is the second most abundant natural polymer and a promissing feedstock for the generation of renewable aromatic chemicals. We present an fundamental approach for the electrocatalytic cleavage of lignin dissolved in a recoverable, inexpensive ionic liquid using mixed metal oxide electrodes of different compositions. The distribution of depolymerization products generated by electrochemical oxidation were analyzed by means of mass spectrometry. The distribution and yield of the cracked species was found to depended strongly on the implemented metal catalyst and therefore offers the potential to tailor the amount and composition of the low molecular weight cleavage products. This approach could help to provide a more sustainable valorization of lignin for the potential production of high value aromatic compounds due to synergistic effects.

Synthesis of N-benzyl-des-D-ring lamellarin K via an acyl-Claisen/Paal-Knorr approach

Dittrich, Nora,Pilkington, Lisa I.,Leung, Euphemia,Barker, David

, p. 1881 - 1894 (2017/03/11)

Lamellarin K is a complex pyrrole natural product and member of the lamellarin family – a group of natural products known for their potent biological activities, such as, antiproliferative activity and inhibition of P-gp mediated drug efflux pumps. We herein describe the synthesis of the N-benzyl-des-D ring analogue of lamellarin K using a route that centres on an acyl-Claisen reaction to eventually prepare a highly-functionalised 1-aryl-4-methyl-1,4-diketone. Paal-Knorr pyrrole formation using this diketone undergoes auto-oxidation to give a fully-substituted 5-formyl pyrrole which was converted into the natural lactone B ring. Antiproliferative testing of the N-benzyl-des-D ring analogue gave an IC50 of 2.63?μM against the MDA-MB-231 breast cancer cell line.

METHOD FOR BIOCATALYTIC SYNTHESIS OF SUBSTITUTED OR UNSUBSTITUTED PHENYLACETIC ACIDS AND KETONES HAVING ENZYMES OF MICROBIAL STYRENE DEGRADATION

-

, (2016/08/03)

The present invention relates to a method for the biocatalytic synthesis of substituted and unsubstituted phenylacetic acids and ketones from styrenes and bicyclic aromatic hydrocarbons using enzymes of microbial styrene degradation in a whole-cell sensor, as well as a kit for the biocatalytic synthesis of substituted and unsubstituted phenylacetic acids and ketones containing a whole-cell catalyst and the use of the method, wherein the method comprises the following steps: a) providing at least one type of whole-cell catalyst, containing genes which code for the enzymes of styrene degradation and are under the functional control of a regulatable promoter, in an aqueous component,b) activating the whole-cell catalyst with an inducer and/or an activator, leading to expression of the gene,c) bringing the activated whole-cell catalyst into contact with a substrate,d) isolating the reaction products produced, which are advantageously not further metabolized by the whole-cell cat and advantageously accumulate in the aqueous component.

New synthesis of vanillin by degradation of lignin in presence of functional basic ionic liquid

Yi, Fengping,Jiang, Xiaoyan,Niu, Jihua,Zhang, Lirong,Wang, Zhen

, p. 885 - 888 (2015/02/05)

The degradation of lignin catalyzed by functional basic ionic liquid was investigated. Higher conversion of lignin and simpler degradation product composition were obtained in the presence of basic ionic liquid, comparing with that under traditional NaOH

2-Diazo-1-(4-hydroxyphenyl)ethanone: A versatile photochemical and synthetic reagent

Senadheera, Sanjeewa N.,Evans, Anthony S.,Toscano, John P.,Givens, Richard S.

, p. 324 - 341 (2014/02/14)

α-Diazo arylketones are well-known substrates for Wolff rearrangement to phenylacetic acids through a ketene intermediate by either thermal or photochemical activation. Likewise, α-substituted p-hydroxyphenacyl (pHP) esters are substrates for photo-Favorskii rearrangements to phenylacetic acids by a different pathway that purportedly involves a cyclopropanone intermediate. In this paper, we show that the photolysis of a series of α-diazo-p- hydroxyacetophenones and p-hydroxyphenacyl (pHP) α-esters both generate the identical rearranged phenylacetates as major products. Since α-diazo-p-hydroxyacetophenone (1a, pHP N2) contains all the necessary functionalities for either Wolff or Favorskii rearrangement, we were prompted to probe this intriguing mechanistic dichotomy under conditions favorable to the photo-Favorskii rearrangement, i.e., photolysis in hydroxylic media. An investigation of the mechanism for conversion of 1a to p-hydroxyphenyl acetic acid (4a) using time-resolved infrared (TRIR) spectroscopy clearly demonstrates the formation of a ketene intermediate that is subsequently trapped by solvent or nucleophiles. The photoreaction of 1a is quenched by oxygen and sensitized by triplet sensitizers and the quantum yields for 1a-c range from 0.19 to a robust 0.25. The lifetime of the triplet, determined by Stern-Volmer quenching, is 31 ns with a rate for appearance of 4a of k = 7.1 × 10 6 s-1 in aq. acetonitrile (1:1 v:v). These studies establish that the primary rearrangement pathway for 1a involves ketene formation in accordance with the photo-Wolff rearrangement. Furthermore we have also demonstrated the synthetic utility of 1a as an esterification and etherification reagent with a variety of substituted α-diazo-p- hydroxyacetophenones, using them as synthons for efficiently coupling it to acids and phenols to produce pHP protect substrates. The Royal Society of Chemistry and Owner Societies.

The effect of hydroxytyrosol and its nitroderivatives on catechol-O-methyl transferase activity in rat striatal tissue

Gallardo, Elena,Madrona, Andrs,Palma-Valds, Roco,Trujillo, Mariana,Espartero, Jos Luis,Santiago, Marti

, p. 61086 - 61091 (2015/02/19)

Hydroxytyrosol is a well-known phenolic compound with antioxidant properties that is found in virgin olive oil. Studies have shown that virgin olive oil has neuroprotective effects in rats; thus the purpose of the present study was to investigate the neuroprotective effect of hydroxytyrosol in rats. Additionally, this study aimed to investigate the neuroprotective potential of a homologous series of compounds with better lipophilic profiles in order to increase the assortment of compounds with a putative effect against Parkinson's disease (PD). In this context, the inhibition of catechol-O-methyl transferase (COMT) activity by hydroxytyrosol, nitrohydroxytyrosol, nitrohydroxytyrosol acetate and ethyl nitrohydroxytyrosol ether was investigated by measuring intracellular dopamine and its metabolite levels in the corpus striatum by high performance liquid chromatography (HPLC) with electrochemical detection. The animals received an acute (single dose; 20 mg kg-1; i.p.) or chronic (one daily dose for 5 days; 20 mg kg-1; i.p.) treatment of hydroxytyrosol and its nitroderivatives. For comparison, a commercial COMT inhibitor, Ro 41-0960, was also included. Our data show that acute and chronic systemic administration of these compounds produced a clear and statistically significant increase in the intracellular levels of dopamine and its metabolite, 3,4-dihydroxyphenylacetic acid. The increase in dopamine levels was very similar to the increase seen with Ro 41-0960 treatment. The effect of chronic treatment was stronger than that of acute treatment. With respect to the intracellular level of homovanillic acid, Ro 41-0960 produced a statistically significant decrease which it was not observed when hydroxytyrosol and its nitroderivatives were systemically administered. However, the chronic homovanillic acid treatment effect was stronger than the acute treatment. The results suggest that these compounds could inhibit COMT activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 306-08-1